Prostate cancer Board decisions

The Board denied the Veteran's claim for a higher rating for prostate cancer, finding that the reduction from 100% to 10% was proper and that there were no residuals of prostate cancer warranting a higher rating.

The Board has remanded the Veteran's claim for prostate cancer service connection due to incomplete records and a need for further development, including obtaining additional medical records from Dr. G. in Klamath Falls.

The Board denied service connection for brain aneurysm, coronary artery disease (CAD), epilepsy secondary to brain aneurysm, hypertension, and prostate cancer. The Veteran's claims were not supported by evidence of in-service exposure or a link between the conditions and service.

The Board has remanded the claims of service connection for diabetes mellitus type II, prostate cancer, and skin cancer (including melanoma) due to herbicide exposure. The AOJ was directed to investigate the Veteran's assertions of herbicide exposure and issue a Formal Finding with a determination as to the likelihood of such exposure. VA examinations were also scheduled to determine if the claimed conditions began during service or are otherwise related to service.

The Veteran's heart disability and prostate cancer prevented him from securing or following a substantially gainful occupation, meeting the criteria for an extraschedular TDIU rating.

The Board has remanded the claims for prostate and bladder cancer residuals due to insufficient information regarding potential exposure to herbicide agents during service in Korea.

The Veteran's prostate cancer is granted service connection due to presumed exposure to herbicide agents during service at Korat RTAFB in Thailand. The Veteran's erectile dysfunction is remanded for further examination and determination of its relationship to his prostate cancer.

The Veteran's claims for service connection for ischemic heart disease, diabetes mellitus type II, prostate cancer, and erectile dysfunction were granted with an effective date of October 1, 1999.

The Board has reopened the claim for service connection for epididymitis and remanded the issue of service connection for prostate cancer. The Veteran's current epididymitis is presumed to have preexisted service, but it is unclear if it was aggravated by service.

The Board has remanded the Veteran's claims for service connection for various genitourinary and musculoskeletal disabilities, including prostate cancer, kidney disability, bladder disability, low back disability, right hip disability, bilateral shoulder disability, and right knee disability. The remand requires obtaining additional medical opinions to address the etiology of these conditions, particularly regarding exposure to contaminated water at Camp Lejeune.

The Board denied service connection for a recurrent left upper extremity disability, claimed as secondary to Parkinson's disease, finding that no such condition was shown during active service or at any time thereafter.

The Veteran's service-connected disabilities do not by themselves cause him to require aid and assistance in accomplishing the activities of daily living and render him unable to protect himself from the hazards and dangers of his daily environment. Therefore, SMC based on the need for aid and attendance is denied.

The Board has remanded the Veteran's claim for an increased rating for prostate cancer and whether the reduction from 100 percent was proper due to incomplete development. The Veteran is already service connected for nephropathy, which affects renal function.

The Veteran's prostate cancer residuals have been rated at 40 percent since September 10, 2015. The Board has determined that a higher rating is not warranted prior to June 16, 2022 and from November 13, 2022.,From June 16, 2022 to November 13, 2022, the Veteran's prostate cancer residuals have been rated at 60 percent.

The Veteran withdrew his appeal regarding the service connection for prostate cancer before a decision was made.

The Board has remanded the claims for residuals of prostate cancer due to concerns about the severity and progression of the disability, particularly since the last VA examination in 2016. The Veteran's representative requested that a VA examiner review his private treatment records and provide an opinion on the current severity of his service-connected condition.

The Board denied service connection for the Veteran's eye disability, acquired psychiatric disability (including panic disorder without agoraphobia), prostate cancer, chronic autoimmune urticaria/angioedema, and hypothyroidism (claimed as thyroid cancer) due to a lack of evidence linking these conditions to his military service.,The Board also denied service connection for hearing loss.

The Board has decided to remand the cases for a more contemporaneous examination of the Veteran's service-connected headache disability due to possible worsening symptoms. The TDIU issue is also remanded as it is inextricably intertwined with the headaches claim.

The Board denied service connection for prostate cancer and a mental disorder, both of which the Veteran claimed were due to exposure to radiation during active service. The evidence did not support these claims.

The Board has decided that the Veteran's prostate cancer is not related to his service at Enewetak Atoll in the Marshall Islands, and thus remanded for further development.